Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Prince HMA"'
Pharmacokinetics of Two Common Antiretroviral Regimens in Older HIV-Infected Patients: A Pilot Study
Autor:
Prince, HMA, Kendrick, RL, Dumond, JB, Forrest, A, White, N, Wang, R, Sykes, C, Jennings, SH, Malone, S, Patterson, KB, Kashuba, ADM, Corbett, AH, Adams, JL
The pharmacokinetics (PK) of antiretrovirals (ARVs) in older HIV-infected patients are poorly described. Here, the steady-state PK of 2 common ARV regimens (tenofovir [TFV]/emtricitabine [FTC]/efavirenz [EFV]; TFV/FTC/atazanavir [ATV]/ritonavir [RTV]
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bf6c8f51651c0a8b29e0c60dc4217752
Autor:
Dumond, JB, Collins, JW, Cottrell, ML, Trezza, CR, Prince, HMA, Sykes, C, Torrice, C, White, N, Malone, S, Wang, R, Patterson, KB, Sharpless, NE, Forrest, A
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology; Feb2017, Vol. 6 Issue 2, p120-127, 8p
Autor:
Dumond, JB, Chen, J, Cottrell, M, Trezza, CR, Prince, HMA, Sykes, C, Torrice, C, White, N, Malone, S, Wang, R, Patterson, KB, Sharpless, NE, Forrest, A
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology; Feb2017, Vol. 6 Issue 2, p128-135, 8p
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology; Mar2016, Vol. 5 Issue 3, p147-157, 11p
Autor:
Dumond, JB, Adams, JL, Prince, HMA, Kendrick, RL, Wang, R, Jennings, SH, Malone, S, White, N, Sykes, C, Corbett, AH, Patterson, KB, Forrest, A, Kashuba, ADM
Publikováno v:
HIV Medicine; Aug2013, Vol. 14 Issue 7, p401-409, 9p
Publikováno v:
JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.); Feb2005, Vol. 18 Issue 2, p68-68, 1p
Autor:
Gilliland WM; Department of Chemistry, Furman University, Greenville, South Carolina 29613, USA., White NR, Yam BH, Mwangi JN, Prince HMA, Weideman AM, Kashuba ADM, Rosen EP
Publikováno v:
The Analyst [Analyst] 2020 Jul 07; Vol. 145 (13), pp. 4540-4550. Date of Electronic Publication: 2020 May 18.
Autor:
Cottrell ML; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Prince HMA; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill., Schauer AP; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Sykes C; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Maffuid K; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Poliseno A; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics., Chun TW; HIV Immunovirology Unit, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Huiting E; HIV Immunovirology Unit, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland., Stanczyk FZ; Keck School of Medicine, University of Southern California, Los Angeles., Peery AF; School of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill., Dellon ES; School of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill., Adams JL; Philadelphia College of Pharmacy, University of the Sciences, Pennsylvania.; Cooper University Hospital Early Intervention Program, Camden, New Jersey., Gay C; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill., Kashuba ADM; Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics.; School of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill.
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2019 Nov 27; Vol. 69 (12), pp. 2201-2204.
Autor:
Greene SA; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; SK Life Science, Inc, Fair Lawn, New Jersey, USA., Chen J; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Merck Co, Philadelphia, Pennsylvania, USA., Prince HMA; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Sykes C; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Schauer AP; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Blake K; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nelson JAE; UNC School of Medicine, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Gay CL; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cohen MS; UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dumond JB; University of North Carolina (UNC), UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2019 Oct; Vol. 106 (4), pp. 821-830. Date of Electronic Publication: 2019 May 31.
Autor:
Gilliland WM Jr; Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States., Prince HMA; Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.; School of Medicine , University of North Carolina , Chapel Hill , North Carolina 27599 , United States., Poliseno A; Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.; School of Medicine , University of North Carolina , Chapel Hill , North Carolina 27599 , United States., Kashuba ADM; Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.; School of Medicine , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.; Center for AIDS Research , University of North Carolina , Chapel Hill , North Carolina 27599 , United States., Rosen EP; Eshelman School of Pharmacy , University of North Carolina , Chapel Hill , North Carolina 27599 , United States.
Publikováno v:
Analytical chemistry [Anal Chem] 2019 Aug 20; Vol. 91 (16), pp. 10816-10822. Date of Electronic Publication: 2019 Aug 06.